Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Sabra Health Care REIT Inc., 3 years.
Sabra Health Care REIT Inc.
Director
Cathay General Bancorp
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Sabra Health Care REIT Inc. | Grant or award | +791 | — | — |
| Jun 17, 2026 | Sabra Health Care REIT Inc. | Grant or award | +8,310 | — | — |
| May 29, 2026 | Sabra Health Care REIT Inc. | Grant or award | +817 | — | — |
| Apr 15, 2026 | Cathay General Bancorp | Grant or award | +1,593 | — | — |
| Feb 27, 2026 | Sabra Health Care REIT Inc. | Grant or award | +781 | — | — |
| Nov 28, 2025 | Sabra Health Care REIT Inc. | Grant or award | +882 | — | — |
| Aug 29, 2025 | Sabra Health Care REIT Inc. | Grant or award | +887 | — | — |
| Jun 12, 2025 | Sabra Health Care REIT Inc. | Grant or award | +8,178 | — | — |
| May 30, 2025 | Sabra Health Care REIT Inc. | Grant or award | +815 | — | — |
| May 15, 2025 | Cathay General Bancorp | Grant or award | +1,913 | — | — |
| Feb 28, 2025 | Sabra Health Care REIT Inc. | Grant or award | +843 | — | — |
| Nov 29, 2024 | Sabra Health Care REIT Inc. | Grant or award | +737 | — | — |
| Aug 30, 2024 | Sabra Health Care REIT Inc. | Grant or award | +793 | — | — |
| Jun 13, 2024 | Sabra Health Care REIT Inc. | Grant or award | +9,480 | — | — |
| May 31, 2024 | Sabra Health Care REIT Inc. | Grant or award | +719 | — | — |
Questions about Ann Kono
What boards is Ann Kono on?
Ann Kono sits on the boards of Cathay General Bancorp and Sabra Health Care REIT Inc.
How long has Ann Kono served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.